Gene expression analysis reveals a strong signature of an interferon induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer

Uri Einav; Yuval Tabach; Gad Getz; Assif Yitzhaky; Ugur Ozbek; Ninette Amariglio; Shai Izraeli; Gideon Rechavi; Eytan Domany

Home/Archive/arXiv

arXiv · q-bio/0511017

Gene expression analysis reveals a strong signature of an interferon induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer

Uri Einav·Yuval Tabach·Gad Getz·Assif Yitzhaky·Ugur Ozbek·Ninette Amariglio·Shai Izraeli·Gideon Rechavi·Eytan Domany

View original source ↗Read source document ↗Export metadata ↓

Abstract

On the basis of epidemiological studies, infection was suggested to play a role in the etiology of human cancer. While for some cancers such a role was indeed demonstrated, there is no direct biological support for the role of viral pathogens in the pathogenesis of childhood leukemia. Using a novel bioinformatic tool, that alternates between clustering and standard statistical methods of analysis, we performed a "double blind" search of published gene expression data of subjects with different childhood ALL subtypes, looking for unanticipated partitions of patients, induced by unexpected groups of genes with correlated expression. We discovered a group of about thirty genes, related to the interferon response pathway, whose expression levels divide the ALL samples into two subgroups; high in 50, low in 285 patients. Leukemic subclasses prevalent in early childhood (the age most susceptible to infection) are over-represented in the high expression subgroup. Similar partitions, induced by the same genes, were found also in breast and ovarian cancer but not in lung cancer, prostate cancer and lymphoma. About 40% of breast cancer samples expressed the "interferon- related" signature. It is of interested that several studies demonstrated MMTV-like sequences in about 40% of breast cancer samples. Our discovery of an unanticipated strong signature of an interferon induced pathway provides molecular support for a role for either inflammation or viral infection in the pathogenesis of childhood leukemia as well as breast and ovarian cancer.

Explore related subjects

q-bio.GN q-bio.MN

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Uri Einav, Yuval Tabach, Gad Getz, Assif Yitzhaky, Ugur Ozbek, Ninette Amariglio, Shai Izraeli, Gideon Rechavi, Eytan Domany. 2005-11-14. Gene expression analysis reveals a strong signature of an interferon induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer. https://arxiv.org/abs/q-bio/0511017

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

EMMA: an R/Bioconductor package to automate tracking of metadata in functional enrichment analyses

Summary: Functional enrichment analysis (FEA) is a widely used approach for interpreting high-throughput omics data. However, essential methodological details, such as software versions, analysis parameters, and annotation database releases among others, are often incompletely reported, limiting the reproducibility and transparency of enrichment analyses and complicating the assessment of potentially problematic methodological choices. Here we present EMMA, an R/Bioconductor package that integrates with existing FEA tools and automatically captures provenance metadata, such as annotation metadata, software version, and parameters, during the analysis runtime. Our package provides utilities for accessing and exporting the recorded metadata to facilitate transparent reporting and preserve provenance required for reproducible enrichment analyses. This also enables auditing of the results while remaining compatible with existing Bioconductor workflows. Availability and implementation: EMMA is available on Bioconductor under the MIT license (https: //bioconductor.org/packages/EMMA), with its development version also available on GitHub (https: //github.com/imbeimainz/EMMA).

q-bio.GN↗

arXiv2026

Motif-Vocab: StatisticallyCalibrated Transcription-Factor-Identity Tokenization forGenomic Language Models

Tokenization is a central design choice in genomic language models, yet most deoxyribonucleic acid (DNA) tokenizers use characters, fixed-length k-mers, or frequency-derived subwords without explicitly using prior information about the specificity of DNA-binding regulatory factors. We introduce Motif-Vocab, a biologically informed tokenizer that scans both DNA strands for statistically calibrated motif matches, emits transcription-factor (TF) identity tokens, and applies nucleotide, $k$-mer, or byte-pair encoding (BPE) to unmatched sequence. Motif-specific null distributions put position-weight matrices (PWMs) of different lengths and degeneracy on a common significance scale; deterministic overlap rules make the representation reproducible. In controlled Bidirectional Encoder Representations from Transformers (BERT) pretraining on two billion base pairs, real motif libraries outperform randomized-motif controls on 54 of 55 in-scope downstream tasks. On a motif-disjoint recognition task derived from DART-Eval Task 2, TF-specific tokens improve macro-F1 by 0.040 over a position-matched generic motif token and by 0.033 over a matched no-motif tokenizer (95\% bootstrap confidence interval: 0.027--0.038). Motif tokens also receive stronger attribution and produce larger occlusion effects than shuffled controls. Dense no-motif tokenizers remain strong general-purpose baselines, including a near-tie on the five-task BERT-base panel. Thus, Motif-Vocab is not a universal accuracy replacement; it is a targeted, interpretable inductive bias for motif-sensitive genomic modeling.

q-bio.GN↗

arXiv2026

Revolutionizing Genomics with Reinforcement Learning Techniques

In recent years, Reinforcement Learning (RL) has emerged as a powerful tool for solving a wide range of problems, including decision-making and genomics. The exponential growth of raw genomic data over the past two decades has exceeded the capacity of manual analysis, leading to a growing interest in automatic data analysis and processing. RL algorithms are capable of learning from experience with minimal human supervision, making them well-suited for genomic data analysis and interpretation. One of the key benefits of using RL is the reduced cost associated with collecting labeled training data, which is required for supervised learning. While there have been numerous studies examining the applications of Machine Learning (ML) in genomics, this survey focuses exclusively on the use of RL in various genomics research fields, including gene regulatory networks (GRNs), genome assembly, and sequence alignment. We present a comprehensive technical overview of existing studies on the application of RL in genomics, highlighting the strengths and limitations of these approaches. We then discuss potential research directions that are worthy of future exploration, including the development of more sophisticated reward functions as RL heavily depends on the accuracy of the reward function, the integration of RL with other machine learning techniques, and the application of RL to new and emerging areas in genomics research. Finally, we present our findings and conclude by summarizing the current state of the field and the future outlook for RL in genomics.

q-bio.GN↗